UPSC Prelims 2022·GS1·science-and-technology·science and technology

In the context of vaccines manufactured to prevent COVID-19 pandemic, consider the following statements : 1. The Serum Institute of India produced COVID-19 vaccine named Covishield using mRNA platform. 2. Sputnik V vaccine is manufactured using vector based platform. 3. COVAXIN is an inactivated pathogen based vaccine. Which of the statements given above are correct?

Dalvoy logo
Reviewed by Dalvoy
UPSC Civil Services preparation
Last updated 23 May 2026, 3:31 pm IST
  1. A1 and 2 only
  2. B2 and 3 onlyCorrect
  3. C1 and 3 only
  4. D1, 2 and 3

Explanation

Let's analyze each statement regarding COVID-19 vaccines: 1. **The Serum Institute of India produced COVID-19 vaccine named Covishield using mRNA platform:** Incorrect. Covishield, manufactured by the Serum Institute of India, is the AstraZeneca vaccine which uses a **viral vector platform** (specifically, a chimpanzee adenovirus vector), not an mRNA platform. mRNA vaccines (like Pfizer-BioNTech and Moderna) use messenger RNA to instruct cells to produce a harmless piece of the spike protein. 2. **Sputnik V vaccine is manufactured using vector based platform:** Correct. The Sputnik V vaccine, developed by Russia's Gamaleya Research Institute, uses two different human adenoviral vectors (Ad26 and Ad5) in a prime-boost approach. This is a classic viral vector platform. 3. **COVAXIN is an inactivated pathogen based vaccine:** Correct. COVAXIN, developed by Bharat Biotech in collaboration with ICMR-NIV, is an inactivated vaccine. This means it uses a whole, inactivated (killed) SARS-CoV-2 virus that cannot cause disease but can still trigger an immune response. Therefore, statements 2 and 3 are correct.
science-and-technology: In the context of vaccines manufactured to prevent COVID-19 pandemic, consider the following statements : 1. The Serum I

Related questions

More UPSC Prelims practice from the same subject and topic.